BUSINESS
Ujjivan stellar listing: What next for investors and those who missed the bus?
Existing investors should build up positions on every decline and new investors should also gradually add Ujjivan Bank with an eye on the long term.
BUSINESS
Can its capital raising rerate RBL Bank?
While the valuation now looks reasonable, the adverse macro environment can continue to provide negative asset quality surprise. Hence, a gradual accumulation is recommended.
BUSINESS
Where is the comfort in large cap IT?
Both HCL Tech and Tech Mahindra have done reasonably well in the past month and we would recommend investors to take advantage of market volatility to build position
BUSINESS
What explains the strength in VIP’s stock and should you buy now?
Since a prolonged economic downturn may further suppress consumer demand and hence earnings outlook for the company, we would advise investors to gradually accumulate the stock on correction
BUSINESS
Will the FM’s real estate push create a virtuous cycle?
In spite of the good intent, the amount committed may just be a drop in the ocean.
BUSINESS
Bank Nifty – Can the outperformance sustain itself?
BUSINESS
Tech Mahindra – Should you buy post the sharp rally?
The stock valuation is reasonable despite the recent rally. Investors should use market volatility and buy Tech Mahindra on decline.
BUSINESS
Yes Bank: Caught between the lure of new capital and drag of toxic assets
It is not unreasonable to assume that fresh capital infusion of a large order could propel a rally in the stock in the medium term
BUSINESS
India Inc’s Q2: How companies have braved the slowdown so far
A clearer picture will emerge once smaller sized companies report earnings. Going by this early trend, that’s unlikely to be a happy picture
BUSINESS
Axis Bank: Its strategy is inspiring, but execution will determine if valuations can improve
We believe that it has the potential to get re-rated if its journey to reach 18 per cent RoE plays out. So, we recommend adding the stock on every decline
BUSINESS
Kotak Mahindra Bank: Asset quality takes away sheen, buy on weakness
Any weakness post results is therefore an opportunity to gradually build position for the long term
BUSINESS
Infosys – Opening Pandora’s box, avoid the stock
In a highly competitive environment, this will benefit peers. We, therefore, advise investors to completely avoid Infosys till the dust settles
BUSINESS
L&T Infotech Q2 – You can spot some early signs of its revival
We are positive about LTI coming out gradually from this rough patch. The eventual integration of IT service businesses remains a long-term driver
BUSINESS
Mindtree – The crisis is gone, but growth is yet to come back
The stock might have some downside, given the overall volatile macro and market environment. Such weakness could present a buying opportunity
BUSINESS
Federal Bank – Too many misses, but right long-term intent
We do not expect a quick recovery in the stock. Investors should gradually build up position in this weak phase
BUSINESS
Wipro Q2 – Little downside, but upside capped as well
We do not see stock outperformance as long as Wipro lags its peers in growth
BUSINESS
IRCTC: After a stellar listing, is it too late to board this train?
While we do not see an immediate upside, IRCTC should definitely be on the radar of long-term investors
BUSINESS
IndusInd Bank – At what price do potential negatives get priced in?
Choice of Managing Director Romesh Sobti’s successor may also have a bearing on stock sentiment
BUSINESS
Yes Bank – Are all the concerns priced in?
Investors with ability to stomach volatility should gradually start building position
BUSINESS
Sector explainer | Hot investment idea? Private banks high on capital fit the bill
In a space crowded with many players, it’s the cost of funds that will set apart the men from the boys
INDIA
RBI policy | Head says 'no rate action', but heart says a 'token rate cut'
BUSINESS
BSE 500 long-term returns show it is all about bottom-up stock picking
BUSINESS
Corporate tax cuts: Game changer or short-term cheer?
The current momentum can lead to a virtuous cycle provided an equally serious look is taken at attracting big-ticket investment in infrastructure, post the tax cut
BUSINESS
Why this microcap niche pharma player surprises amid the smallcap carnage
We draw comfort from the relatively insulated business model and the undemanding valuation.
